Cost-effectiveness of treating chronic hepatitis C virus with direct-acting antivirals in people who inject drugs in Australia.
Scott N, Iser DM, Thompson AJ, Doyle JS, Hellard ME
Targeted direct-acting antiviral treatment for chronic hepatitis C: A financial reality or an obstacle to elimination?
Hellard M, Pedrana A, Scott N
Longitudinal changes in psychological distress in a cohort of people who inject drugs in Melbourne, Australia.
Scott N, Carrotte ER, Higgs P, Cogger S, Stoové MA, Aitken CK, Dietze PM
Individual-level needle and syringe coverage in Melbourne, Australia: a longitudinal, descriptive analysis.
O'Keefe D, Scott N, Aitken C, Dietze P
Limited provision of diagnostic services to Victorians living with hepatitis C antibodies, 2001-2012: a multi-level modelling analysis.
Snow K, Scott N, Clothier HJ, MacLachlan JH, Cowie B